Schedule 13D ownership disclosure
DA32 Life Science Tech Acquisition Corp.
Security class unavailable · CUSIP: 23312M106
Event date: 2021-07-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 26.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-240746
- Form type
- SC 13D
- Filer
- ARCH Venture Fund XI, L.P.
- CIK
- CIK 1831802
- Filed
- Aug 10, 2021
- Reporting period
- Jul 30, 2021
- Description
- Schedule 13D beneficial ownership